Eugenia L.L. Yeo

966 total citations
25 papers, 783 citations indexed

About

Eugenia L.L. Yeo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Eugenia L.L. Yeo has authored 25 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Biomaterials. Recurrent topics in Eugenia L.L. Yeo's work include Nanoparticle-Based Drug Delivery (7 papers), Gold and Silver Nanoparticles Synthesis and Applications (7 papers) and Nanoplatforms for cancer theranostics (6 papers). Eugenia L.L. Yeo is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Gold and Silver Nanoparticles Synthesis and Applications (7 papers) and Nanoplatforms for cancer theranostics (6 papers). Eugenia L.L. Yeo collaborates with scholars based in Singapore, United States and France. Eugenia L.L. Yeo's co-authors include James Chen Yong Kah, K. G. Neoh, Patricia S. P. Thong, Khee Chee Soo, Melvin L.K. Chua, Dennis Poon, Xiang Zheng, Pakorn Kanchanawong, Akshaya Bansal and Yong Zhang and has published in prestigious journals such as Nature Communications, Cancer Research and Langmuir.

In The Last Decade

Eugenia L.L. Yeo

22 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugenia L.L. Yeo Singapore 14 431 248 244 217 120 25 783
Jiayu Ren China 10 457 1.1× 277 1.1× 337 1.4× 263 1.2× 90 0.8× 16 867
Jiwen Qian China 16 659 1.5× 307 1.2× 393 1.6× 269 1.2× 117 1.0× 18 937
Genhua Liu China 16 655 1.5× 201 0.8× 221 0.9× 325 1.5× 146 1.2× 29 1.0k
Karina Pombo‐García Germany 9 354 0.8× 426 1.7× 377 1.5× 321 1.5× 51 0.4× 11 1.1k
Anqing Wu China 10 238 0.6× 217 0.9× 221 0.9× 201 0.9× 48 0.4× 17 588
Ulrike Kauscher United Kingdom 17 289 0.7× 369 1.5× 217 0.9× 229 1.1× 102 0.8× 19 802
Alisar S. Zahr United States 8 257 0.6× 302 1.2× 360 1.5× 171 0.8× 70 0.6× 8 942
Ping Wei China 14 735 1.7× 331 1.3× 587 2.4× 352 1.6× 67 0.6× 22 1.3k
Ara S. Moses United States 4 567 1.3× 326 1.3× 533 2.2× 297 1.4× 64 0.5× 4 1.2k
Xiuxia He China 12 541 1.3× 244 1.0× 242 1.0× 387 1.8× 43 0.4× 25 877

Countries citing papers authored by Eugenia L.L. Yeo

Since Specialization
Citations

This map shows the geographic impact of Eugenia L.L. Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia L.L. Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia L.L. Yeo more than expected).

Fields of papers citing papers by Eugenia L.L. Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia L.L. Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia L.L. Yeo. The network helps show where Eugenia L.L. Yeo may publish in the future.

Co-authorship network of co-authors of Eugenia L.L. Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia L.L. Yeo. A scholar is included among the top collaborators of Eugenia L.L. Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia L.L. Yeo. Eugenia L.L. Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeo, Eugenia L.L., et al.. (2025). Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer. Experimental Hematology and Oncology. 14(1). 5–5.
3.
Yeo, Eugenia L.L., Enya H.W. Ong, Joe Yeong, et al.. (2023). Association of Claudin-1 overexpression with immune exclusion in nasopharyngeal carcinoma and its potential as a novel therapeutic target.. JCO Global Oncology. 9(Supplement_1). 151–151. 1 indexed citations
5.
Yeo, Eugenia L.L., et al.. (2021). Stealthiness and Hematocompatibility of Gold Nanoparticles with Pre-Formed Protein Corona. Langmuir. 37(16). 4913–4923. 9 indexed citations
6.
Tan, Hong Qi, Eugenia L.L. Yeo, Dennis Poon, et al.. (2020). Dosimetric uncertainties impact on cell survival curve with low energy proton. Physica Medica. 76. 277–284. 1 indexed citations
7.
Mi, Xue, et al.. (2019). Mannitol-induced gold nanoparticle aggregation for the ligand-free detection of viral particles. The Analyst. 144(18). 5486–5496. 16 indexed citations
8.
Poon, Dennis, Bhuvaneswari Ramaswamy, Zhongguo Liang, et al.. (2019). Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment. Photodiagnosis and Photodynamic Therapy. 27. 367–374. 17 indexed citations
9.
Zhang, Zhen, Muthu Kumara Gnanasammandhan Jayakumar, Xiang Zheng, et al.. (2019). Upconversion superballs for programmable photoactivation of therapeutics. Nature Communications. 10(1). 4586–4586. 124 indexed citations
10.
Wang, Haitao, Eugenia L.L. Yeo, Gek San Tan, et al.. (2019). Immune dysregulation underpins radioresistance in nasopharyngeal carcinoma (NPC).. Journal of Global Oncology. 5(suppl). 52–52.
11.
Yeo, Eugenia L.L., et al.. (2019). Gold Nanorods Coated with Apolipoprotein E Protein Corona for Drug Delivery. ACS Applied Nano Materials. 2(10). 6220–6229. 30 indexed citations
13.
Yeo, Eugenia L.L., You‐Quan Li, Khee‐Chee Soo, Joseph Wee, & Melvin L.K. Chua. (2018). Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma. Chinese Clinical Oncology. 7(2). 15–15. 34 indexed citations
14.
Yeo, Eugenia L.L., et al.. (2017). Protein Corona around Gold Nanorods as a Drug Carrier for Multimodal Cancer Therapy. ACS Biomaterials Science & Engineering. 3(6). 1039–1050. 34 indexed citations
15.
Yeo, Eugenia L.L., Wah Ing Goh, Pakorn Kanchanawong, et al.. (2016). Exploiting the protein corona around gold nanorods for low-dose combined photothermal and photodynamic therapy. Journal of Materials Chemistry B. 5(2). 254–268. 78 indexed citations
16.
Jeffries, Clark, Diana O. Perkins, Sharon D. Chandler, et al.. (2016). Insights into psychosis risk from leukocyte microRNA expression. Translational Psychiatry. 6(12). e981–e981. 22 indexed citations
17.
Yeo, Eugenia L.L., et al.. (2014). An instantaneous colorimetric protein assay based on spontaneous formation of a protein corona on gold nanoparticles. The Analyst. 140(4). 1026–1036. 42 indexed citations
18.
Zhang, Pengfei, et al.. (2013). Dark-field circular depolarization optical coherence microscopy. Biomedical Optics Express. 4(9). 1683–1683. 4 indexed citations
19.
Kah, James Chen Yong, et al.. (2013). Nanoparticle Interface to Biology: Applications in Probing and Modulating Biological Processes. Critical Reviews in Biomedical Engineering. 41(4-5). 323–341. 5 indexed citations
20.
Yeo, Eugenia L.L., et al.. (2003). Development of an improved ERP system using GPS and an intelligent search technique. 8. 944–949. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026